Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1035 results for "iprs"

ED attaches Rs 13 crore properties of IPRS

MUMBAI: The Enforcement Directorate (ED) on Wednesday attached properties worth Rs 13 crore of the Indian Performing Rights Society (IPRS) under the prevention of money laundering act (PMLA). The company allegedly collected music loyalties from ... Times of India, 2 weeks ago
ED attaches body’s movable property Asian Age, 2 weeks ago

173 images for iprs

Financial Express, 3 days ago, 1 day ago
International Business Times India, 2 days ago, 4 days ago, 4 days ago, 4 days ago
Times of India, 3 days ago
Voice Of Sikkim, 5 days ago
Financial Express, 2 weeks ago, 5 days ago

IPC releases IP national reference standards, IPRS-Vaccines

Keen to focus on setting the quality standards of vaccines throughout the country, the Indian Pharmacopoeia Commission (IPC) released the much anticipated national reference standards, the Indian Pharmacopoeia Reference Substances (IPRS-Vaccines).
 PharmaBiz2 weeks ago
Business Standard

NGOs urge PM to ‘resist pressure’ from U.S. on IPRs

Govt. to ensure transparency on engagements with the U.S. on IPR
 The Hindu3 weeks ago NGOs tell PM not to succumb to pressure from US on IPR  Economic Times2 weeks ago NGOs tell PM Modi not to succumb to pressure from US on IPR  Business Standard2 weeks ago

USIBC team to push for ‘stronger’ IPRs

USIBC will deliberate with the stakeholders and Indian government on a study, which among other things, recommended stronger Intellectual Property Rights (IPR) protection in India to boost Foreign Direct Investment (FDI) inflows. CL is the grant of permission ...
 The Hindu2 months ago

New IPR regime aims at promoting R&D

The government will put in place an institutional mechanism to nurture and commercialise intellectual property rights (IPRs). This is aimed at promoting creativity, innovation and entrepreneurship across sectors. The Union cabinet on Thursday cleared a ...
 The Financial Chronicle1 month ago 6 Golden Rules When Reviewing Cloud Contracts  Mason Hayes+Curran2 days ago India to have Cloud Computing Law; TRAI asks for feedback  CIO & Leader3 days ago Why India-US engagements get patently jittery?  Business Line2 weeks ago

Early IPRs Challenging Biologic Patents: What We Know

Multiple IPRs challenging patents covering brand-name biologics have now been filed by biosimilar developers, for reasons we recently discussed , as well as by other entities. Institution decisions in these early IPRs and a small number of final ...
 Lexology4 days ago IPRs emerge from SC challenge alive, robust  Medical Device Daily5 days ago SCOTUS backs biopharma's most-hated patent challenges  FiercePharma5 days ago

BioSimilar Battle Expands at PTAB

HUMIRA® Subject to Additional IPRs Guest Post by Tia Fenton & Jeff McIntyre As discussed previously, biosimilar applicants can gain significant strategic advantage by availing themselves of Patent Trial & Appeal Board (PTAB) patent challenge ...
 Lexology5 days ago

Coherus BioSciences Provides Update on IPRs

(GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq:CHRS), a leading pure-play, global biosimilars company with late-stage clinical products, today announced that it has received a favorable decision from the Patent Trial and Appeal Board (PTAB) ...
 4 Traders1 week ago BRIEF-Coherus BioSciences provides update on IPRs  Reuters UK1 week ago Coherus gets good news on USPTO review of Humira patents  Seeking Alpha1 week ago
JD Supra

Survey of Pharmaceutical IPRs Filed By Generic Drug Company Petitioners

We have reviewed a sub-group of 111 IPRs filed by generic drug companies against pharmaceutical patents to assess outcomes and trends. While our surveywas not intended to capture every IPR filed by a generic drug company, it does cover the most ...
 National Law Review2 weeks ago
Broadway World

NETWORK 1 SECURITY SOLUTIONS : U.S. PTAB Rules in Favor of Network-1 in Pending IPRs of Cox Patents

Microsoft Word - IPR COX PRESS RELEASE (6 20 16) v7 FOR IMMEDIATE RELEASE Corey M. Horowitz, Chairman and CEO Network-1 Technologies, Inc. (212) 829-5770 U.S. Patent Trial and Appeal Board Rules in Favor of Network-1 in Pending Inter Partes Review ...
 4 Traders1 day ago Lessons For Persuading the Patent Board: Straight From Judges Mouths  National Law Review5 days ago NETWORK 1 TECHNOLOGIES : U.S. Patent Trial and Appeal Board Rules in Favor of Network-1 in Pending Inter Partes Review of Cox Patents  4 Traders5 days ago U.S. Patent Trial and Appeal Board Rules in Favor of Network-1 in Pending Inter Partes Review of Cox Patents  ITbriefing5 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - iprs
Get updated on latest news & your favorite topics right in your inbox!
More     Less